V. Frisardi

发表

Gerontechnology for demented patients: smart homes for smart aging.

V. Frisardi, B. Imbimbo, Vincenza Frisardi, 2011, Journal of Alzheimer's disease : JAD.

Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing

Eden R Martin, Seth Love, Brian Lawlor, 2019, Nature Genetics.

Metabolic-cognitive syndrome: A cross-talk between metabolic syndrome and Alzheimer's disease

Daniele Sancarlo, Alberto Pilotto, F. Panza, 2010, Ageing Research Reviews.

Metabolic syndrome as a risk factor for neurological disorders

F. Panza, A. A. Farooqui, T. Farooqui, 2011, Cellular and Molecular Life Sciences.

Dietary patterns and protection against Alzheimer disease and cognitive decline.

F. Panza, D. Seripa, A. Pilotto, 2010, Archives of neurology.

Parkinson's Disease: New Insights into Pathophysiology and Rehabilitative Approaches

B. Cheeran, V. Frisardi, A. Santamato, 2016, Parkinson's disease.

Botulinum toxin type A in the treatment of focal hand dystonia after surgical treatment for thumb duplication.

F. Panza, V. Solfrizzi, P. Fiore, 2009, Orthopedics.

POSSIBLE PREDICTORS OF VASCULAR COGNITIVE IMPAIRMENT–NO DEMENTIA

F. Panza, D. Seripa, A. Pilotto, 2009, Journal of The American Geriatrics Society.

Meta-analysis of genetic association with diagnosed Alzheimer’s disease identifies novel risk loci and implicates Abeta, Tau, immunity and lipid processing

J. Gallacher, M. Fornage, I. Giegling, 2018, bioRxiv.

Metabolic Syndrome and Autophagy: Focus on HMGB1 Protein

V. Frisardi, C. Matrone, M. Street, 2021, Frontiers in Cell and Developmental Biology.

Cognitive behavioural group therapy in mild cognitive impairment: intervention with a cognitive or behavioural/psychological focus?

F. Panza, V. Solfrizzi, V. Frisardi, 2009, Journal of rehabilitation medicine.

BEYOND CORONARY ARTERY DISEASE: ROSUVASTATIN IN OLDER PATIENTS WITH ISCHEMIC SYSTOLIC HEART FAILURE

F. Panza, V. Solfrizzi, A. Capurso, 2008, Journal of the American Geriatrics Society.

Development of Approaches and Metrics to Measure the Impact and Improve the Clinical Outcomes of Patients With Frailty in the Era of COVID-19. The COMETA Italian Protocol

G. Ciliberto, M. Costantini, G. Piaggio, 2022, Frontiers in Oncology.

EFFECT OF DONEPEZIL ON THE CONTINUUM OF DEPRESSIVE SYMPTOMS, MILD COGNITIVE IMPAIRMENT, AND PROGRESSION TO DEMENTIA

F. Panza, V. Solfrizzi, A. Capurso, 2010, Journal of the American Geriatrics Society.

Gamification in Late-Life Depression: A Serious Game for a Serious Problem

V. Frisardi, Roberto Caragnulo, 2020, Biomedical Journal of Scientific & Technical Research.

PLASMA LIPID DISTURBANCES AND COGNITIVE DECLINE

F. Panza, D. Seripa, A. Pilotto, 2010, Journal of the American Geriatrics Society.

Towards disease-modifying treatment of Alzheimer's disease: drugs targeting beta-amyloid.

F. Panza, D. Seripa, A. Pilotto, 2010, Current Alzheimer research.

Dietary unsaturated fatty acids and risk of mild cognitive impairment.

F. Panza, D. Seripa, A. Pilotto, 2010, Journal of Alzheimer's disease : JAD.

Author Correction: Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing

Nick C Fox, Michelle K. Lupton, Charles C. White, 2019, Nature Genetics.

Botulinum toxin type A and type B for sialorrhoea in Parkinson's disease: a case for switching therapy?

F. Panza, V. Solfrizzi, V. Frisardi, 2008, Journal of rehabilitation medicine.

Pulmonary rehabilitation for patients with bronchiectasis: case reports.

F. Panza, C. Cisari, S. Filoni, 2012, European journal of physical and rehabilitation medicine.

Moderate alcohol consumption, apolipoprotein E, and neuroprotection.

F. Panza, V. Solfrizzi, A. Capurso, 2009, Archives of neurology.

Mental Health Among Medical Professionals During the COVID-19 Pandemic in Eight European Countries: Cross-sectional Survey Study

A. Rashid, A. König, Ó. Ribeiro, 2020, Journal of medical Internet research.

Mental Health Among Medical Professionals During the COVID-19 Pandemic in Eight European Countries: Cross-sectional Survey Study

A. Rashid, A. König, Ó. Ribeiro, 2020, Journal of medical Internet research.

Proposing a Scientific and Technological Approach to the Summaries of Clinical Issues of Inpatient Elderly with Delirium: A Viewpoint

V. Frisardi, N. Cautero, M. Nicolini, 2022, Healthcare.

APOLIPOPROTEIN E, DEMENTIA, AND HUMAN LONGEVITY

F. Panza, D. Seripa, A. Pilotto, 2009, Journal of the American Geriatrics Society.

Whole‐Diet Approach: Working on a Criterion Validity for Age‐Related Cognitive Decline and Mild Cognitive Impairment

F. Panza, V. Solfrizzi, A. Capurso, 2009, Journal of the American Geriatrics Society.

Botulinum toxin type A in the treatment of painful adductor muscle contracture after total hip arthroplasty.

F. Panza, V. Solfrizzi, P. Fiore, 2009, Orthopedics.

Aluminum in the diet and Alzheimer's disease: from current epidemiology to possible disease-modifying treatment.

P. Kehoe, F. Panza, D. Seripa, 2010, Journal of Alzheimer's disease : JAD.

Late-life depression, mild cognitive impairment, and dementia: possible continuum?

Alberto Pilotto, Alessia D'Introno, F. Panza, 2010, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

Immunotherapy for Alzheimer's disease: from anti-β-amyloid to tau-based immunization strategies.

G. Logroscino, F. Panza, D. Seripa, 2012, Immunotherapy.

Apolipoprotein E genotypes and neuropsychiatric symptoms and syndromes in late-onset Alzheimer's disease

G. Logroscino, F. Panza, D. Seripa, 2012, Ageing Research Reviews.

Aluminium in the Diet, Cognitive Decline and Dementia

P. Kehoe, F. Panza, V. Solfrizzi, 2011 .

Aluminum in the diet and Alzheimer's disease: from current epidemiology to possible disease-modifying treatment.

P. Kehoe, F. Panza, D. Seripa, 2010, Journal of Alzheimer's disease : JAD.

Beyond the neurotransmitter-focused approach in treating Alzheimer’s Disease: drugs targeting β-amyloid and tau protein

F. Panza, D. Seripa, A. Pilotto, 2009, Aging clinical and experimental research.

Effectiveness of the frequency rhythmic electrical modulation system for the treatment of chronic and painful venous leg ulcers in older adults.

F. Panza, D. Seripa, P. Fiore, 2012, Rejuvenation research.

Effectiveness of botulinum toxin type A treatment of neck pain related to nocturnal bruxism: a case report.

F. Panza, V. Solfrizzi, P. Fiore, 2010, Journal of chiropractic medicine.

Alcohol drinking, cognitive functions in older age, predementia, and dementia syndromes.

F. Panza, D. Seripa, A. Pilotto, 2009, Journal of Alzheimer's disease : JAD.

Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing

Nick C Fox, Michelle K. Lupton, Charles C. White, 2019, Nature Genetics.

REVIEW: γ‐Secretase Inhibitors for the Treatment of Alzheimer's Disease: The Current State

G. Logroscino, F. Panza, D. Seripa, 2010, CNS neuroscience & therapeutics.

Towards Disease-Modifying Treatment of Alzheimers Disease: Drugs Targeting β -Amyloid

F. Panza, D. Seripa, A. Pilotto, 2009 .

This material is the copyright of the original publisher. Unauthorised copying and distribution is prohibited. Disease-Modifying Approach to the Treatment of Alzheimer's Disease From a-Secretase Activators to c-Secretase Inhibitors and Modulators

F. Panza, V. Solfrizzi, A. Capurso, 2009 .

Disease-Modifying Approach to the Treatment of Alzheimer’s Disease

F. Panza, V. Solfrizzi, A. Capurso, 2009, Drugs & aging.

Therapeutic intervention for Alzheimer's disease with γ-secretase inhibitors: still a viable option?

G. Logroscino, F. Panza, D. Seripa, 2011, Expert opinion on investigational drugs.

Interacting with γ-secretase for treating Alzheimer's disease: from inhibition to modulation.

G. Logroscino, F. Panza, D. Seripa, 2011, Current medicinal chemistry.

Frailty syndrome and the risk of vascular dementia: The Italian Longitudinal Study on Aging

G. Logroscino, D. Inzitari, F. Panza, 2010, Alzheimer's & Dementia.

Metabolic syndrome and the risk of vascular dementia: the Italian Longitudinal Study on Ageing

D. Inzitari, F. Panza, A. Di Carlo, 2009, Journal of Neurology, Neurosurgery & Psychiatry.

Normalizing the dementia status in cardiovascular diseases: a perspective

V. Frisardi, 2022, Journal of geriatric cardiology : JGC.

Metabolic syndrome, mild cognitive impairment, and dementia.

F. Panza, D. Seripa, A. Pilotto, 2011, Current Alzheimer research.

Short-term effects of high-intensity laser therapy versus ultrasound therapy in the treatment of low back pain: a randomized controlled trial.

F. Panza, V. Solfrizzi, P. Fiore, 2011, European journal of physical and rehabilitation medicine.

Short-term Effects of High-Intensity Laser Therapy Versus Ultrasound Therapy in the Treatment of People With Subacromial Impingement Syndrome: A Randomized Clinical Trial

F. Panza, V. Solfrizzi, P. Fiore, 2009, Physical Therapy.

Apolipoprotein E genotype: the innocent bystander or active bridge between metabolic syndrome and cognitive impairment?

V. Frisardi, 2012, Journal of Alzheimer's disease : JAD.

Interleukin 6–174 G/C promoter and variable number of tandem repeats (VNTR) gene polymorphisms in sporadic Alzheimer's disease

F. Panza, D. Seripa, A. Pilotto, 2010, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Glycerophospholipids and glycerophospholipid-derived lipid mediators: a complex meshwork in Alzheimer's disease pathology.

F. Panza, D. Seripa, A. A. Farooqui, 2011, Progress in lipid research.

All-cause mortality and competing risks of fatal and nonfatal vascular events in the Italian longitudinal study on aging: impact of lipoprotein(a).

F. Panza, V. Solfrizzi, A. Capurso, 2009, Rejuvenation research.

Metabolic syndrome and cognitive impairment: current epidemiology and possible underlying mechanisms.

Daniele Sancarlo, Grazia D'Onofrio, Alberto Pilotto, 2010, Journal of Alzheimer's disease : JAD.

Polyunsaturated Fatty Acid and S-Adenosylmethionine Supplementation in Predementia Syndromes and Alzheimer's Disease: A Review

F. Panza, V. Solfrizzi, A. Capurso, 2009, TheScientificWorldJournal.

Possible role of S-adenosylmethionine, S-adenosylhomocysteine, and polyunsaturated fatty acids in predementia syndromes and Alzheimer's disease.

F. Panza, V. Solfrizzi, A. Capurso, 2009, Journal of Alzheimer's disease : JAD.

Neuropsychiatric Symptoms, Endophenotypes, and Syndromes in Late-Onset Alzheimer's Disease: Focus on APOE Gene

P. Mecocci, F. Panza, D. Seripa, 2011, International journal of Alzheimer's disease.

Alcohol consumption in mild cognitive impairment and dementia: harmful or neuroprotective?

G. Logroscino, F. Panza, D. Seripa, 2012, International journal of geriatric psychiatry.

PLASMA LEVELS OF N‐3 POLYUNSATURATED FATTY ACIDS AND COGNITIVE DECLINE: POSSIBLE ROLE OF DEPRESSIVE SYMPTOMS AND APOLIPOPROTEIN E GENOTYPING

F. Panza, D. Seripa, A. Pilotto, 2010, Journal of the American Geriatrics Society.

Apolipoprotein E-related all-cause mortality in hospitalized elderly patients

M. Copetti, F. Panza, D. Seripa, 2010, AGE.

Solanezumab for the treatment of mild-to-moderate Alzheimer’s disease

F. Panza, D. Seripa, A. Pilotto, 2012, Expert review of clinical immunology.

Bapineuzumab: anti-β-amyloid monoclonal antibodies for the treatment of Alzheimer's disease.

F. Panza, D. Seripa, A. Pilotto, 2010, Immunotherapy.

Angiotensin-converting enzyme inhibitors and incidence of mild cognitive impairment. The Italian Longitudinal Study on Aging

P. Kehoe, G. Logroscino, D. Inzitari, 2013, AGE.

Nutraceutical properties of Mediterranean diet and cognitive decline: possible underlying mechanisms.

Alberto Pilotto, F. Panza, D. Seripa, 2010, Journal of Alzheimer's disease : JAD.

Dietary fatty acids in dementia and predementia syndromes: Epidemiological evidence and possible underlying mechanisms

F. Panza, V. Solfrizzi, A. Capurso, 2010, Ageing Research Reviews.

Advances in the identification of γ-secretase inhibitors for the treatment of Alzheimer's disease

F. Panza, D. Seripa, A. Pilotto, 2012, Expert opinion on drug discovery.

Advances in the identification of g-secretase inhibitors for the treatment of Alzheimer's disease

F. Panza, D. Seripa, A. Pilotto, 2012 .

γ-secretase inhibitors for treating Alzheimer’s disease: rationale and clinical data

F. Panza, D. Seripa, A. Pilotto, 2011 .

g-secretase inhibitors for treating Alzheimer’s disease: rationale and clinical data

F. Panza, D. Seripa, A. Pilotto, 2011 .

Diet and Alzheimer’s disease risk factors or prevention: the current evidence

Giancarlo Logroscino, Alberto Pilotto, G. Logroscino, 2011, Expert review of neurotherapeutics.

Peripheral antioxidant markers in mild cognitive impairment and its progression to dementia.

F. Panza, D. Seripa, A. Pilotto, 2010, Journal of Alzheimer's Disease.

Late-life depression and Alzheimer's disease: The glutamatergic system inside of this mirror relationship

F. Panza, A. A. Farooqui, V. Frisardi, 2011, Brain Research Reviews.

Impact of COVID-19 pandemic on outpatient visit volume in cancer patients: Results of COMETA multicenter retrospective observational study

G. Ciliberto, A. Neri, V. Frisardi, 2023, Frontiers in Public Health.

G. Logroscino, F. Panza, D. Seripa, 2012 .

Metabolic-cognitive syndrome: metabolic approach for the management of Alzheimer's disease risk.

V. Frisardi, B. Imbimbo, 2012, Journal of Alzheimer's disease : JAD.

Efficacy and safety of higher doses of botulinum toxin type A NT 201 free from complexing proteins in the upper and lower limb spasticity after stroke

G. Logroscino, F. Panza, P. Fiore, 2013, Journal of Neural Transmission.

Effectiveness of switching therapy from complexing protein-containing botulinum toxin type A to a formulation with low immunogenicity in spasticity after stroke: a case report.

F. Panza, P. Fiore, S. Filoni, 2012, Journal of rehabilitation medicine.

Role of biphosphonates and lymphatic drainage type Leduc in the complex regional pain syndrome (shoulder-hand syndrome).

F. Panza, V. Solfrizzi, P. Fiore, 2009, Pain medicine.

Different models of frailty in predementia and dementia syndromes

F. Panza, D. Seripa, A. Pilotto, 2011, The journal of nutrition, health & aging.

Vascular risk factors, alcohol intake, and cognitive decline

F. Panza, D. Seripa, A. Pilotto, 2008, The journal of nutrition, health & aging.

Mediterranean diet in predementia and dementia syndromes.

G. Logroscino, F. Panza, D. Seripa, 2011, Current Alzheimer research.

Alcohol Consumption in Predementia and Dementia Syndromes

P. Kehoe, F. Panza, V. Solfrizzi, 2011 .

MILD COGNITIVE IMPAIRMENT: DEMENTIA RISK FACTOR OR HIGH‐RISK STATE FOR PROGRESSION TO DEMENTIA?

F. Panza, V. Solfrizzi, A. Capurso, 2008, Journal of the American Geriatrics Society.

Temporal relationship between depressive symptoms and cognitive impairment: the Italian Longitudinal Study on Aging.

R. Caselli, F. Panza, V. Solfrizzi, 2009, Journal of Alzheimer's disease : JAD.

Effect of botulinum toxin type A, motor imagery and motor observation on motor function of hemiparetic upper limb after stroke

P. Kehoe, F. Panza, V. Solfrizzi, 2010, Brain injury.

Metabolic syndrome as a risk factor for neurological disorders

F. Panza, A. A. Farooqui, T. Farooqui, 2012, Cellular and Molecular Life Sciences.

Dietary Fatty Acids, Cognitive Decline, and Dementia

F. Panza, V. Solfrizzi, A. Capurso, 2011 .

Dietary Fatty Acids and Predementia Syndromes

F. Panza, V. Solfrizzi, A. Capurso, 2009, TheScientificWorldJournal.

Is insulin resistant brain state a central feature of the metabolic-cognitive syndrome?

F. Panza, D. Seripa, A. Pilotto, 2010, Journal of Alzheimer's disease : JAD.

Monoclonal antibodies against β-amyloid (Aβ) for the treatment of Alzheimer's disease: the Aβ target at a crossroads

F. Panza, D. Seripa, A. Pilotto, 2011, Expert opinion on biological therapy.

Mediterranean dietary pattern, mild cognitive impairment, and progression to dementia.

F. Panza, V. Solfrizzi, A. Capurso, 2009, Archives of neurology.

Metabolic syndrome, mild cognitive impairment, and progression to dementia. The Italian Longitudinal Study on Aging

D. Inzitari, F. Panza, S. Maggi, 2011, Neurobiology of Aging.

Anti-β-amyloid immunotherapy for Alzheimer's disease: focus on bapineuzumab.

Grazia D'Onofrio, Giancarlo Logroscino, Alberto Pilotto, 2011, Current Alzheimer research.

Impact of metabolic syndrome on cognitive decline in older age: protective or harmful, where is the pitfall?

V. Frisardi, 2014, Journal of Alzheimer's disease : JAD.

Paraplegia due to Anterior Spinal Artery Stroke: Rehabilitative Program on Lower Extremity Weakness and Locomotor Function

F. Panza, A. Pilotto, P. Fiore, 2013 .

Commentary: Coronavirus and Obesity: Could Insulin Resistance Mediate the Severity of Covid-19 Infection?

V. Frisardi, 2020, Frontiers in Public Health.

Metabolic syndrome , cognitive performance and dementia : A review

J. Buckley, J. Bryan, K. Murphy, 2017 .

Metabolic syndrome, cognitive performance, and dementia.

J. Buckley, J. Bryan, K. Murphy, 2012, Journal of Alzheimer's disease : JAD.

Frailty syndrome and all-cause mortality in demented patients: the Italian Longitudinal Study on Aging

G. Logroscino, D. Inzitari, F. Panza, 2012, AGE.

Acoustic analysis of swallowing sounds: a new technique for assessing dysphagia.

Maurizio Ranieri, Marisa Megna, Pietro Fiore, 2009, Journal of rehabilitation medicine.

Dietary fatty acids, age-related cognitive decline, and mild cognitive impairment

F. Panza, D. Seripa, A. Pilotto, 2008, The journal of nutrition, health & aging.

MILD COGNITIVE IMPAIRMENT DIETARY FATTY ACIDS , AGE-RELATED COGNITIVE DECLINE , AND MILD COGNITIVE IMPAIRMENT

F. Panza, D. Seripa, A. Pilotto, 2008 .

Polymorphisms in glutathione S-transferase omega-1 gene and increased risk of sporadic Alzheimer disease.

F. Panza, D. Seripa, A. Pilotto, 2010, Rejuvenation research.

Calcium channel blockers and Alzheimer's disease: potential relevance in treatment strategies of metabolic syndrome.

Patrick G Kehoe, P. Kehoe, V. Frisardi, 2012, Journal of Alzheimer's disease : JAD.

Unmet Psychosocial Needs of Health Care Professionals in Europe During the COVID-19 Pandemic: Mixed Methods Approach.

C. Lemogne, V. Frisardi, S. Weidt, 2023, JMIR Public Health and Surveillance.

How do geriatricians evaluate decision-making ability for older adults with cognitive impairment? Results from an European survey

P. Soysal, J. Tournoy, V. Frisardi, 2023, European Geriatric Medicine.

New horizons in digital innovation and technology in dementia: potential and possible pitfalls

P. Soysal, S. Shenkin, V. Frisardi, 2022, European Geriatric Medicine.

Might Fibroblasts from Patients with Alzheimer’s Disease Reflect the Brain Pathology? A Focus on the Increased Phosphorylation of Amyloid Precursor Protein Tyr682 Residue

L. Annunziato, V. Frisardi, C. Matrone, 2021, Brain sciences.

Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing

Genetic, Nick C Fox, Michelle K. Lupton, 2019, Nature Genetics.

Immunotherapy for Alzheimer's disease: from anti-β-amyloid to tau-based immunization strategies.

G. Logroscino, F. Panza, D. Seripa, 2012, Immunotherapy.

Therapeutic intervention for Alzheimer's disease with γ-secretase inhibitors: still a viable option?

G. Logroscino, F. Panza, D. Seripa, 2011, Expert opinion on investigational drugs.

REVIEW: γ‐Secretase Inhibitors for the Treatment of Alzheimer's Disease: The Current State

G. Logroscino, F. Panza, D. Seripa, 2010, CNS neuroscience & therapeutics.

Frailty syndrome and all-cause mortality in demented patients: the Italian Longitudinal Study on Aging

G. Logroscino, D. Inzitari, F. Panza, 2011, AGE.

Effect of intrathecal baclofen, botulinum toxin type A and a rehabilitation programme on locomotor function after spinal cord injury: a case report.

F. Panza, V. Solfrizzi, P. Fiore, 2010, Journal of rehabilitation medicine.

Whole‐Diet Approach: Working on a Criterion Validity for Age‐Related Cognitive Decline and Mild Cognitive Impairment

F. Panza, V. Solfrizzi, A. Capurso, 2009, Journal of the American Geriatrics Society.

The Italian Framework of Bipolar Disorders in the Elderly: Old and Current Issues and New Suggestions for the Geriatric Psycho-Oncology Research

M. Menchetti, R. Chattat, F. Neviani, 2023, Biomedicines.